Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Nigel Farage defends plan to bar immigrants with HIV from NHS care

    Farage, speaking during an LBC radio phone-in, was confronted by a Briton with HIV who accused him of “playing the race card” and that ramping up fear would make people with HIV hide rather than seek the treatment they needed.

    10 October 2014 | The Guardian
  • As Hepatitis Pill Harvoni Joins Sovaldi, States Erect Medicaid Hurdles

    As Gilead Sciences launches its next generation Hepatitis C pill, Harvoni, Medicaid programs are bracing for another extraordinary wave of costs, with 70 percent of states implementing coverage restrictions.

    10 October 2014 | Forbes
  • Less Than Half of HIV-Positive US Hispanics Are Getting Proper Care

    Even though Hispanics in the United States become infected with HIV at rates triple those of whites, less than half of Hispanics with the virus are receiving adequate treatment, a new report finds.

    10 October 2014 | U.S. News & World Report
  • Thousands of Hep C patients in Alexandria wait in long lines to receive Sovaldi

    Thousands of Hepatitis C virus patients have flooded two medical centers in Alexandria in hopes of receiving the new Hep C Sovaldi drug, after the health ministry said it will be providing it for patients.

    10 October 2014 | Egypt Independent
  • Sovaldi ‘unaffordable’ says NHS documents

    Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after new data shows it would cost the health service £1 billion a year to fund.

    08 October 2014 | Pharmafile
  • How Some State Medicaid Programs Limit Drugs to Only the Sickest Patients

    Because of its high cost, some state Medicaid programs and prison systems are refusing to provide Sovaldi to any but the sickest patients. Most recently, Oregon last month threatened to limit access to the drug unless it can get Sovaldi at a deeply discounted price. What can states do to hold down drug costs? Drug pricing is a complicated and opaque process. Here are some of the basics.

    07 October 2014 | Governing.com
  • Thai patients to receive free HIV drugs, regardless of CD4 count

    The Thai Public Health Ministry has started distributing free antiretroviral drugs to all HIV patients in a move to expand treatment coverage and place them under the state's monitoring system. Previously, HIV patients would receive the drugs only if their number of CD4 cells — which mark the presence of HIV antibodies — decreased to 350, compared with 500 in normal people. From Wednesday, all HIV patients would have access to the drugs without the need for a CD4 count, Deputy Public Health Minister Somsak Chunharas said on Wednesday.

    02 October 2014 | Bangkok Post
  • Exclusive: India set to run out of critical free drug for HIV/AIDS program

    India could run out of a critical medicine in its free HIV/AIDS drugs program in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month.

    01 October 2014 | Reuters
  • UNITAID: Tuberculosis diagnostics technology and market landscape – 3rd edition

    UNITAID releases today its 2014 Tuberculosis Diagnostics Technology and Market Landscape, detailing the promising pipeline of products and technologies to diagnose tuberculosis (TB). The report highlights current and emerging technologies from over 80 manufacturers and developers, including products which are smaller, simpler and easier to use.

    01 October 2014 | EATG
  • Patent landscape for hepatitis issued by WHO

    The World Health Organization has published an analysis of the patent situation for new hepatitis treatments, and a call for possible pharmaceutical products for prequalification.

    29 September 2014 | Intellectual Property Watch
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.